Rajaram Rohan, Zhang Min, Premaratne Gehan, Ng Sally
Department of Plastic and Reconstructive Surgery, Austin Health, Heidelberg, VIC, Australia.
Department of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, VIC, Australia.
Front Bioeng Biotechnol. 2024 Nov 13;12:1450973. doi: 10.3389/fbioe.2024.1450973. eCollection 2024.
Novosorb Biodegradable Temporising Matrix (BTM) is an entirely synthetic dermal matrix that is gaining popularity in the management of challenging wounds. Not only does it provide a framework in which to grow an organised neodermis, it is also especially resistant to infection. Today, the matrix is available as a 2 mm thick open cell polyurethane foam with a non-degrading sealing membrane. Its current form is the result of numerous and experiments that examined its shape, biodegradation, inflammatory response, and cytotoxicity. Clinical data on the use of BTM in a variety of cases is novel and presents early insights into its ability to foster wound healing where otherwise improbable. This review presents the history and development of Novosorb BTM as well as all the currently available clinical data on its efficacy in difficult wounds such as: major burns, necrotising soft tissue infection, chronic wounds and in non graftable wound beds.
诺沃索布生物可降解临时基质(BTM)是一种完全合成的真皮基质,在具有挑战性伤口的处理中越来越受欢迎。它不仅提供了一个用于生长有组织新真皮的框架,而且对感染具有特别的抵抗力。如今,该基质以一种2毫米厚的开孔聚氨酯泡沫形式存在,并带有一层不可降解的密封膜。其当前的形式是经过大量研究其形状、生物降解、炎症反应和细胞毒性的实验后得出的结果。关于BTM在各种病例中使用的临床数据是新颖的,并且初步揭示了其在其他情况下难以实现的促进伤口愈合的能力。本综述介绍了诺沃索布BTM的历史和发展,以及目前所有关于其在诸如大面积烧伤、坏死性软组织感染、慢性伤口和不可移植伤口床等难愈伤口治疗效果的临床数据。